Abstract
The European guidelines on critical chronic ischemia (CCI) recommend identifying the sub-groups of patients at risk. Sarcopenia was highlighted as a factor of poor prognosis in the infra-inguinal revascularizations, but the evaluation of sarcopenia based on the preoperative CT can be regarded as tedious in current practice. The platelets/lymphocytes ratio (PLR) is a marker of sarcopenia used in other specialties, like digestive surgery or oncology. The aim of this study was to evaluate if PLR could be a fast marker of sarcopenia in patients with CCI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
